| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 298 | 3.902 | 3.330 | 1.179 | 682 | 24 | 0 | 0 | 0 | 2.010 |
| Total Income - EUR | 298 | 3.902 | 3.330 | 1.179 | 682 | 24 | 0 | 0 | 0 | 2.010 |
| Total Expenses - EUR | 456 | 807 | 1.520 | 875 | 367 | 68 | 0 | 0 | 0 | 0 |
| Gross Profit/Loss - EUR | -157 | 3.095 | 1.810 | 304 | 315 | -44 | 0 | 0 | 0 | 2.010 |
| Net Profit/Loss - EUR | -166 | 2.977 | 1.710 | 268 | 295 | -45 | 0 | 0 | 0 | 1.689 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Due Exe Labs Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 225 | 3.253 | 4.859 | 5.029 | 5.235 | 5.080 | 4.968 | 4.983 | 4.968 | 6.629 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 1.496 | 19 | 0 | 42 | 41 | 40 | 41 | 40 | 40 |
| Cash | 225 | 1.757 | 4.841 | 5.029 | 5.192 | 5.039 | 4.927 | 4.943 | 4.928 | 6.589 |
| Shareholders Funds | -121 | 2.857 | 4.519 | 4.704 | 4.908 | 4.770 | 4.664 | 4.679 | 4.665 | 6.327 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 346 | 396 | 341 | 325 | 327 | 310 | 303 | 304 | 303 | 302 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6201 - 6201" | |||||||||
| CAEN Financial Year |
6201
|
|||||||||
Comments - Due Exe Labs Srl